Context

Diabetes is a leading metabolic disorder with a substantial cost burden, especially in inpatient settings. The complexity of inpatient glycemic management has led to the emergence of inpatient diabetes management service (IDMS), a multidisciplinary team approach to glycemic management.

Objective

To review recent literature on the financial and clinical impact of IDMS in hospital settings.

Methods

We searched PubMed using a combination of controlled vocabulary and keyword terms to describe the concept of IDMS and combined the search terms with a comparative effectiveness filter for costs and cost analysis developed by the National Library of Medicine.

Findings

In addition to several improved clinical endpoints such as glycemic management outcomes, IDMS implementation is associated with hospital cost savings through decreased length of stay, preventing hospital readmissions, hypoglycemia reduction, and optimizing resource allocation. There are other downstream potential cost savings in long-term patient health outcomes and avoidance of litigation related to suboptimal glycemic management.

Conclusion

IDMS may play an important role in helping both academic and community hospitals to improve the quality of diabetes care and reduce costs. Clinicians and policymakers can utilize existing literature to build a compelling business case for IDMS to hospital administrations and state legislatures in the era of value-based healthcare.

中文翻译：

---

住院糖尿病管理服务的财务影响

语境

糖尿病是一种主要的代谢性疾病，具有巨大的成本负担，尤其是在住院环境中。住院患者血糖管理的复杂性导致了住院糖尿病管理服务（IDMS）的出现，这是一种多学科团队的血糖管理方法。

客观的

回顾有关 IDMS 在医院环境中的财务和临床影响的最新文献。

方法

我们使用受控词汇和关键词术语的组合来搜索 PubMed，以描述 IDMS 的概念，并将搜索术语与国家医学图书馆开发的成本和成本分析的比较效果过滤器相结合。

发现

除了血糖管理结果等多项临床终点的改善外，IDMS 的实施还可以通过缩短住院时间、防止再入院、减少低血糖和优化资源分配来节省医院成本。在长期患者健康结果方面还有其他潜在的下游成本节省，并避免与次优血糖管理相关的诉讼。

结论

IDMS 可能在帮助学术医院和社区医院提高糖尿病护理质量和降低成本方面发挥重要作用。在基于价值的医疗保健时代，临床医生和政策制定者可以利用现有文献为医院管理部门和州立法机构构建令人信服的 IDMS 商业案例。